Gut microbiota: Anti-cancer therapies affected by gut microbiota.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Ginger volatile oil inhibits the growth of MDA-MB-231 in the bisphenol A environment by altering gut microbial diversity.Heliyon · 2024
   Article
2. Tumor microenvironment is not an 'innocent bystander' in the resistance to treatment of head and neck cancers (Review).Experimental and therapeutic medicine · 2021
   Review
3. Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice.International journal of molecular sciences · 2020
   Review
4. Impact of Fermentable Fibres on the Colonic Microbiota Metabolism of Dietary Polyphenols Rutin and Quercetin.International journal of environmental research and public health · 2019
   Article
5. Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma.Annals of oncology : official journal of the European Society for Medical Oncology · 2019
   Review
6. From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation.Frontiers in behavioral neuroscience · 2018
   Review
7. The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the "MS Microbiome".Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2018
   Review
8. Metagenomic surveys of gut microbiota.Genomics, proteomics & bioinformatics · 2015
   Review

Corrections and comments

• Comment on
  Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.2013
• Comment on
  The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.2013

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as